Update on invasive fungal disease

Future Microbiology

Volumn 6, Issue 9, 2011, Pages 985-989

  Pagano, Livio ^a   Lumb, Joanna ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b Medical Writer   (United Kingdom)

Author keywords

antifungal resistance; Candida guidelines; candidemia; caspofungin; posaconazole

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; CANDIDIASIS; CLINICAL PRACTICE; CONFERENCE PAPER; EPIDEMIOLOGICAL DATA; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL COOPERATION; INVASIVE CANDIDIASIS; MEDICAL LITERATURE; NONHUMAN; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMIC MYCOSIS;

ANIMALS; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, INVASIVE; DRUG RESISTANCE, FUNGAL; EUROPE; HEMATOLOGIC NEOPLASMS; HUMANS; INTENSIVE CARE; PRACTICE GUIDELINES AS TOPIC;

CANDIDA;

EID: 80053473941     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.85     Document Type: Conference Paper

References (18)

1. Ullmann AJ. ESCMID diagnostic and management guideline for Candida diseases 2011. Presented at: 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)/27th International Congress of Chemotherapy. Milan, Italy, 7-10 May 2011.
2. Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update. Clin. Infect. Dis. 48, 503-535 (2009).
3. Kullberg B-J. Antifungal drugs make me mad: candins or azoles. Presented at: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)/27th International Congress of Chemotherapy. Milan, Italy, 7-10 May 2011.
4. Nucci M, Anaissie E, Betts RF, et al. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect. Dis. 51, 295-303 (2010).
5. Pfaller M, Arendrup M. Susceptibility and resistance: what does it mean and why should it matter? Presented at: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)/27th International Congress of Chemotherapy. Milan, Italy, 7-10 May 2011.
6. Müller E. My daily clinical practice: a multidisciplinary approach to the management of invasive fungal infection in the ICU. Presented at: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)/27th International Congress of Chemotherapy. Milan, Italy, 7-10 May 2011.
7. Kett DH, Azoulay E, Echeverria PM, et al. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit. Care Med. 39, 665-670 (2011).
8. Calandra T. Antifungal management strategies: the ICU patient. Presented at: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)/27th International Congress of Chemotherapy. Milan, Italy, 7-10 May 2011.
9. Ruhnke M. Fungal infections in the ICU: invasive candidiasis. Presented at: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)/27th International Congress of Chemotherapy. Milan, Italy, 7-10 May 2011.
10. Ullmann A. My daily clinical practice: a multidisciplinary approach to the management of invasive fungal infection in patients with haematological malignancy. Presented at: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)/27th International Congress of Chemotherapy. Milan, Italy, 7-10 May 2011.
11. Maertens J. Antifungal management strategies: the haematological patient. Presented at: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)/27th International Congress of Chemotherapy. Milan, Italy, 7-10 May 2011.
12. Adriaenssens N, Coenen S, Versporten A. European Surveillance of Antimicrobial Consumption: trends in systemic azole consumption in hospital care in Europe. ECCMID/ICC. R2417 www.eccmid-icc2011.org
13. Vehreschild M, Heinz W, Hamprecht A, et al. Fungiscope -a global rare fungal infection registry. ECCMID/ICC. P2115 www.eccmid-icc2011.org
14. Pemán J, Cantón E, Pazos C, et al. Epidemiology of fungaemia in Spain: preliminary results of 1,177 episodes from a multicentre study (FUNGEMYCA) in 2009. ECCMID/ICC. P2116 www.eccmid-icc2011.org
15. Vazquez J, Reboli A, Pappas P, et al. A Phase IV, open-label study evaluating efficacy and safety of intravenous anidulafungin followed by oral azole for the treatment of candidemia/invasive candidiasis in US/Korean patients. ECCMID/ICC. O153 www.eccmid-icc2011.org
16. Candoni A, Simeone E, Caira M, et al. Prophylaxis of invasive fungal diseases with posaconazole in acute myeloid leukaemia: a real-life experience. ECCMID/ICC. R2644 www.eccmid-icc2011.org
17. Candoni A, Caira M, Cesaro S, et al. Survey of antifungal combination therapy for treatment of proven or probable invasive fungal diseases in Italian haematological centres. The Seifem-Combo study. ECCMID/ICC. O154 www.eccmid-icc2011.org
18. Valerio M, Muňoz P, Zamora E, et al. Stewardship in antifungals. How much do prescribing physicians know? ECCMID/ICC. O157 www.eccmid-icc2011.org